Niagen Bioscience (NAGE) Change in Inventory (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Change in Inventory data on file, last reported at $3.6 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at $3.6 million, up 79.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.2 million (up 1108.78% YoY), and the FY2025 annual result was $11.6 million, up 318.17% from the prior year.
• Change in Inventory climbed to $3.6 million in Q1 2026 per NAGE's latest filing, from $2.0 million in the prior quarter.
• Over five years, Change in Inventory peaked at $4.4 million in Q3 2025 and troughed at -$2.8 million in Q1 2023.
• A 5-year average of $635235.3 and a median of $446000.0 in 2022 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2023 and 2024: Change in Inventory surged 656.41% in 2023, then plunged 1613.85% in 2024.
• A 5-year view of Change in Inventory shows it stood at -$959000.0 in 2022, then jumped by 298.23% to $1.9 million in 2023, then plunged by 171.12% to -$1.4 million in 2024, then soared by 250.59% to $2.0 million in 2025, then jumped by 75.49% to $3.6 million in 2026.
• Business Quant data shows NAGE's Change in Inventory at $3.6 million in Q1 2026, $2.0 million in Q4 2025, and $4.4 million in Q3 2025.